| Manuel Betancourt Torres, MD | |
|
B89 Calle Rio Canovanillas, Urb. River Edge Hills, Luquillo, PR 00773 | |
| (787) 404-3955 | |
| Not Available |
| Full Name | Manuel Betancourt Torres |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 9 Years |
| Location | B89 Calle Rio Canovanillas, Luquillo, Puerto Rico |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023492568 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Auxilio Mutuo Hospital | Hato rey, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oncology And Body Imaging Psc | 1557790110 | 11 |
News Archive
A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as providing new clues to how the condition may be treated in the future.
Poor diagnosis worldwide of fungal disease causes doctors to overprescribe antibiotics, increasing harmful resistance to antimicrobial drugs, according to a paper published today in Emerging Infectious Diseases.
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
An Indiana University study found that elite college athletes - typically the picture of health and vitality - often struggle to stay active in later years, facing limitations to their day-to-day activities in middle age that could be a result of injuries during their athletic career.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
› Verified 6 days ago
| Entity Name | Oncology & Body Imaging Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699309161 PECOS PAC ID: 1557790110 Enrollment ID: O20200402000048 |
News Archive
A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as providing new clues to how the condition may be treated in the future.
Poor diagnosis worldwide of fungal disease causes doctors to overprescribe antibiotics, increasing harmful resistance to antimicrobial drugs, according to a paper published today in Emerging Infectious Diseases.
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
An Indiana University study found that elite college athletes - typically the picture of health and vitality - often struggle to stay active in later years, facing limitations to their day-to-day activities in middle age that could be a result of injuries during their athletic career.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
› Verified 6 days ago
| Entity Name | Simaging Diagnostic & Interventions-sima |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942939947 PECOS PAC ID: 3779951967 Enrollment ID: O20221118001874 |
News Archive
A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as providing new clues to how the condition may be treated in the future.
Poor diagnosis worldwide of fungal disease causes doctors to overprescribe antibiotics, increasing harmful resistance to antimicrobial drugs, according to a paper published today in Emerging Infectious Diseases.
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
An Indiana University study found that elite college athletes - typically the picture of health and vitality - often struggle to stay active in later years, facing limitations to their day-to-day activities in middle age that could be a result of injuries during their athletic career.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manuel Betancourt Torres, MD Po Box 364426, San Juan, PR 00936-4426 Ph: (787) 925-9255 | Manuel Betancourt Torres, MD B89 Calle Rio Canovanillas, Urb. River Edge Hills, Luquillo, PR 00773 Ph: (787) 404-3955 |
News Archive
A study involving over 5,000 people living with the joint disorder ankylosing spondylitis has identified a series of genetic variants associated with increased susceptibility to the condition as well as providing new clues to how the condition may be treated in the future.
Poor diagnosis worldwide of fungal disease causes doctors to overprescribe antibiotics, increasing harmful resistance to antimicrobial drugs, according to a paper published today in Emerging Infectious Diseases.
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
An Indiana University study found that elite college athletes - typically the picture of health and vitality - often struggle to stay active in later years, facing limitations to their day-to-day activities in middle age that could be a result of injuries during their athletic career.
Arrowhead Research Corporation today announced publication in Proceedings of the National Academy of Sciences (PNAS) of a study using Nanotope's lead compound for cartilage regeneration. The study's authors, which include Nanotope co-founder Dr. Samuel Stupp, showed that Nanotope's bioactive nanofiber system promotes the growth of new cartilage in a rabbit model. The treatment is engineered to repair cartilage defects by working with an animal's own bone marrow stem cells to stimulate the production of new natural cartilage.
› Verified 6 days ago